ID16974A - Komposisi dan metoda pembuatan antibiotik karbapenem - Google Patents

Komposisi dan metoda pembuatan antibiotik karbapenem

Info

Publication number
ID16974A
ID16974A IDP971736A ID971736A ID16974A ID 16974 A ID16974 A ID 16974A ID P971736 A IDP971736 A ID P971736A ID 971736 A ID971736 A ID 971736A ID 16974 A ID16974 A ID 16974A
Authority
ID
Indonesia
Prior art keywords
compibition
carbapenems
making antibiotic
making
antibiotic carbapenems
Prior art date
Application number
IDP971736A
Other languages
English (en)
Indonesian (id)
Inventor
Jeffrey A Zimmermann
John M Williams
Paul A Bergquist
Lisa M Dimichele
David C Dubost
Michael J Kaufman
Daniel R Sidler
William A Hunke
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16974(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ID16974A publication Critical patent/ID16974A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDP971736A 1996-05-28 1997-05-26 Komposisi dan metoda pembuatan antibiotik karbapenem ID16974A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (1)

Publication Number Publication Date
ID16974A true ID16974A (id) 1997-11-27

Family

ID=26309530

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971736A ID16974A (id) 1996-05-28 1997-05-26 Komposisi dan metoda pembuatan antibiotik karbapenem

Country Status (34)

Country Link
EP (1) EP0863901B1 (ja)
JP (2) JPH11509871A (ja)
KR (2) KR100403497B1 (ja)
CN (1) CN1067074C (ja)
AT (1) ATE252584T1 (ja)
AU (1) AU710102B2 (ja)
BG (1) BG63821B1 (ja)
CA (1) CA2227994C (ja)
CO (1) CO4940412A1 (ja)
CY (1) CY2437B1 (ja)
CZ (1) CZ296381B6 (ja)
DE (1) DE69725696T2 (ja)
DK (1) DK0863901T3 (ja)
DZ (1) DZ2242A1 (ja)
EA (1) EA000534B1 (ja)
EE (1) EE04678B1 (ja)
ES (1) ES2208907T3 (ja)
HK (1) HK1016176A1 (ja)
HR (1) HRP970281B1 (ja)
HU (1) HU229426B1 (ja)
ID (1) ID16974A (ja)
IL (1) IL123078A (ja)
IS (1) IS2353B (ja)
MX (1) MX9800808A (ja)
NO (1) NO323815B1 (ja)
NZ (1) NZ329649A (ja)
PL (1) PL188917B1 (ja)
PT (1) PT863901E (ja)
RS (1) RS49583B (ja)
SI (1) SI0863901T1 (ja)
SK (1) SK284359B6 (ja)
TR (1) TR199800146T1 (ja)
TW (1) TW434014B (ja)
WO (1) WO1997045430A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2268820A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
WO1998057973A1 (en) * 1997-06-16 1998-12-23 Merck & Co., Inc. Stabilized carbapenem intermediates and synthetic use
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
EP1244444B1 (en) * 1999-10-29 2004-12-29 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
JPWO2009075309A1 (ja) 2007-12-12 2011-04-28 大日本住友製薬株式会社 製剤組成物
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
WO2009150630A2 (en) * 2008-06-11 2009-12-17 Ranbaxy Laboratories Limited Process for preparing a carbapenem antibiotic composition
CN102365266B (zh) 2009-03-31 2013-11-06 三菱综合材料株式会社 含氟n-烷基磺酰亚胺化合物及其制造方法、以及离子性化合物的制造方法
BRPI1014338B1 (pt) 2009-06-25 2019-12-24 Shell Int Research método para injetar água em uma formação contendo hidrocarbonetos, e, método para preparar uma água com salinidade elevada
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
BR112013010725B1 (pt) 2010-11-05 2018-12-04 Shell Internationale Research Maatschappij B.V. método para tratamento de biomassa para a produção de açúcares a partir de materiais contendo polissacarídeos, para uso em biocombustíveis ou outros produtos de elevado valor, e, composição
WO2012088108A1 (en) 2010-12-20 2012-06-28 Shell Oil Company Process for the production of alcohols from biomass
CN103987851B (zh) 2011-12-15 2016-06-01 国际壳牌研究有限公司 处理来自乙醇生产的副产物的方法
WO2013173569A1 (en) 2012-05-17 2013-11-21 Shell Oil Company Methods and systems for processing biomass material
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
WO2015160887A1 (en) 2014-04-17 2015-10-22 Shell Oil Company Processes for producing fermentation products
BR112016030664B1 (pt) 2014-08-14 2021-06-29 Shell Internationale Research Maatschappij B.V. Método para produzir furfural a partir de material de biomassa contendo pentosano

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
EE9800022A (et) 1998-08-17
JPH11509871A (ja) 1999-08-31
DE69725696T2 (de) 2004-07-29
CN1067074C (zh) 2001-06-13
SK284359B6 (sk) 2005-02-04
HRP970281A2 (en) 1998-06-30
KR19990036052A (ja) 1999-05-25
PL188917B1 (pl) 2005-05-31
IS2353B (is) 2008-04-15
DE69725696D1 (de) 2003-11-27
CZ296381B6 (cs) 2006-03-15
NO323815B1 (no) 2007-07-09
KR100344479B1 (ko) 2002-10-31
JP5255983B2 (ja) 2013-08-07
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
ES2208907T3 (es) 2004-06-16
EA000534B1 (ru) 1999-10-28
CO4940412A1 (es) 2000-07-24
SI0863901T1 (en) 2004-04-30
ATE252584T1 (de) 2003-11-15
DK0863901T3 (da) 2004-02-16
HRP970281B1 (en) 2002-04-30
DZ2242A1 (fr) 2002-12-18
CN1198162A (zh) 1998-11-04
NZ329649A (en) 1998-11-25
JP2009084284A (ja) 2009-04-23
BG102273A (bg) 1998-09-30
HK1016176A1 (en) 1999-10-29
SK10998A3 (en) 1998-08-05
YU4198A (sh) 1998-12-23
CA2227994A1 (en) 1997-12-04
IL123078A0 (en) 1998-09-24
IL123078A (en) 2002-03-10
EE04678B1 (et) 2006-08-15
CA2227994C (en) 2002-06-25
HUP9901567A2 (hu) 1999-09-28
AU3077597A (en) 1998-01-05
EP0863901B1 (en) 2003-10-22
HUP9901567A3 (en) 2000-03-28
KR100403497B1 (ko) 2003-10-30
EP0863901A1 (en) 1998-09-16
WO1997045430A1 (en) 1997-12-04
NO980380D0 (no) 1998-01-28
HU229426B1 (en) 2013-12-30
EA199800180A1 (ru) 1998-08-27
NO980380L (no) 1998-03-16
AU710102B2 (en) 1999-09-16
PT863901E (pt) 2004-02-27
BG63821B1 (bg) 2003-02-28
IS4663A (is) 1998-01-27
RS49583B (sr) 2007-04-10
CY2437B1 (en) 2004-11-12
CZ25398A3 (cs) 1998-07-15
MX9800808A (es) 1998-04-30
TW434014B (en) 2001-05-16

Similar Documents

Publication Publication Date Title
ID16974A (id) Komposisi dan metoda pembuatan antibiotik karbapenem
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
AU3215597A (en) Method of inhibiting fibrosis with a somatostatin agonist
AU6114699A (en) Naphthrydine compounds and their azaisosteric analogues as antibacterials
IL139862A0 (en) Thiazolidine or pyrrolidine derivatives as dipeptidyl peptidase iv effectors and pharmaceutical compositions containing the same
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
EP1023062A4 (en) ANTIBACTERIAL CARBAPENEMAS, COMPOSITIONS AND METHODS OF TREATMENT
BR9712628A (pt) Derivados de 8(9)-deidroestradiol
EP0937718A4 (en) ANTIBIOTIC TKR2648 AND PROCESS FOR PRODUCING THE SAME
MX9804797A (es) Nuevos compuestos con efecto analgesico.
MX9804798A (es) Nuevos compuestos con efecto analgesico.